| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |